Revvity Inc. (RVTY)
NYSE: RVTY
· Real-Time Price · USD
92.00
-0.83 (-0.89%)
At close: May 05, 2025, 3:59 PM
-0.89% (1D)
Bid | 91.11 |
Market Cap | 11.05B |
Revenue (ttm) | 2.77B |
Net Income (ttm) | 309.38M |
EPS (ttm) | 2.42 |
PE Ratio (ttm) | 38.02 |
Forward PE | 17.12 |
Analyst | Buy |
Ask | 98.66 |
Volume | 14,431 |
Avg. Volume (20D) | 1,211,143 |
Open | 91.89 |
Previous Close | 92.83 |
Day's Range | 91.40 - 92.53 |
52-Week Range | 88.53 - 129.50 |
Beta | 1.02 |
About RVTY
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences resea...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jul 6, 1965
Employees 11,000
Stock Exchange NYSE
Ticker Symbol RVTY
Website https://www.perkinelmer.com
Analyst Forecast
According to 13 analyst ratings, the average rating for RVTY stock is "Buy." The 12-month stock price forecast is $125, which is an increase of 35.87% from the latest price.
Stock ForecastsEarnings Surprise
Revvity has released their quartely earnings
on Apr 28, 2025:
1 week ago
+0.82%
RVTY stock has given up its prior gain. Revvity sh...
Unlock content with
Pro Subscription
1 week ago
+0.82%
Revvity shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance with its midpoint above estimates.